Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.20
-0.91 (-4.31%)
At close: Aug 14, 2025, 3:59 PM
20.20
0.00%
Pre-market: Aug 15, 2025, 08:16 AM EDT

Neurogene Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-84.39M -80.87M -75.14M -53.25M -47.61M -31.2M -28.48M -44.31M -29.75M -43.35M -44.5M -46.22M -61.65M -61.09M -60.69M -58.16M -44.97M -39.59M
Depreciation & Amortization
3.13M 3.18M 3.25M 3.28M 3.3M 2.85M 2.64M 2.46M 1.63M 1.98M 2.02M 2.01M 2.6M 2.43M 2.28M 2.1M 1.95M 2.16M
Stock-Based Compensation
12.42M 11.32M 8.32M 6.19M 4.1M 2.17M 1.42M 1.06M 677.63K 293.94K 1.25K 936.00 618.00 309.00 n/a n/a n/a n/a
Other Working Capital
-997.28K -2.34M -6.12M -4.37M -5.99M -6.45M -3.27M -4.36M -5.33M -2.17M -300.57K -1.12M 1.81M -1.2M -696.18K 689.33K -2.26M -1.18M
Other Non-Cash Items
-4.71M -2.5M -832K -34.81M -25.53M -25.96M -20.61M 17.97M 9.88M 13.58M 11.85M 11.99M 16.91M 16.69M 15.34M 12.66M 9.02M 6.39M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
253K -859K -6.19M -4.03M -5.62M -6.31M -3.27M -4.36M -5.33M -2.17M -300.57K -1.12M 1.81M -1.2M -696.18K 689.33K -2.26M -1.18M
Operating Cash Flow
-73.3M -69.73M -70.6M -82.62M -71.36M -59.57M -50.96M -31.11M -26.83M -33.91M -34.97M -37.36M -45.53M -48.03M -47.3M -44.98M -37.33M -32.21M
Capital Expenditures
-1.21M -1.52M -808K -456.78K -290.15K 35.91K -318.09K -629.54K -629.17K -724.47K -757.47K -1.07M -1.61M -2.61M -3.25M -3.55M -3.54M -3.27M
Cash Acquisitions
n/a n/a n/a -2.12M -2.12M -1 -1 2.12M 2.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-284.31M -223.91M -134.94M 75.57M 55.46M 28.38M 1.00 -115.23M -78.42M -90.24M -61.87M -38.91M -38.91M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
69.2M 88.35M 73.65M -36.56M -10.12M -4.55M 4.95M 132.15M 96.96M 72.23M 32.73M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
47.15M -63.16M -63.16M -42.39M -21.54M 20.77M 20.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-169.18M -200.24M -125.26M -5.96M 21.39M 44.63M 25.4M 18.42M 20.03M -18.73M -29.89M -39.98M -40.52M -2.61M -3.25M -3.55M -3.54M -3.27M
Debt Repayment
-40K -56K -52K 298.8K 309.55K 26.26K 32.26K -305.23K -303.98K -4.7K -697.37 -49.73K -49.69K -51.72K -50.72K -2.77K -48.53K -48.44K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.94M 3.9M -3.25M 84.37M 84.37M 84.58M 91.83M 325.29K 325.3K 111.02K -975.63 -975 -991.98 0.08 0.08 0.56 0.54 0.16
Financial Cash Flow
190.25M 190.6M 184.07M 86.01M 85.88M 85.19M 91.65M -348.6K -347.34K 9.15K 208.15K 300.03K 320.01K 579.01K 728.01K 3.15M 76.36M 76.29M
Net Cash Flow
-52.22M -79.37M -11.79M 41.24M 79.75M 114.48M 110.32M -15.11M -9.24M -55.38M -67.4M -78.29M -86.98M -51.04M -36.63M -23.3M -14.6M n/a
Free Cash Flow
-74.51M -71.25M -71.41M -83.08M -71.65M -59.54M -51.27M -31.74M -27.46M -34.63M -35.72M -38.43M -47.14M -50.64M -50.54M -48.53M -40.87M -35.48M